therivabio.com (TOVX): Narxning prognoz qilingan daromadga nisbati

TOVX (Theriva Biologics Inc) - kompaniyaning tovar belgisi

Theriva Biologics, Inc. (TOVX) immunoterapiyani ishlab chiqishga AI modellari va avtomatlashtirishni integratsiya qilmoqda, bunda biznes muvaffaqiyati virusli o'smalar davolash samaradorligiga bog'liq. Muhim bosqich media kontaminatsiyasini bartaraf etish uchun yopiq bioreaktorlarning joriy etilishi bo'ldi. Forward P/S koeffitsiyenti bozor kutganlarini aks ettiradi, bunda ushbu ko'rsatkich hozirda 21.20 darajasida bo'lib, kompaniyaning kelgusidagi savdo aylanmasining bahosini belgilaydi.

TOVX Theriva Biologics Inc: Bozor kapitallashuvining kelajakdagi daromadga nisbati 08.05.2026 - 18.11.2026 oraligʻida

Theriva Biologics, Inc. (TOVX) kompaniyasining tahliliy kesimlari

- birja kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahlili:therivabio.com TOVX
Theriva Corp tomonidan chiqariladigan mahsulotlar

Theriva Biologics, Inc. (TOVX) sog'liqni saqlash gigantlari bilan hamkorlikda o'smalarga qarshi immunoterapiya platformalarini ishlab chiqishdagi muvaffaqiyati emitentning kelgusidagi pul oqimlarini belgilaydi. Forward daromad ko'paytirgichini tahlil qilish orqali investor joriy bozor qiymatining kutilayotgan savdo hajmi nisbatini baholaydi, bu esa narxga kiritilgan o'sish sur'atlarini va aksiyaning bozor tebranishlariga chidamlilik darajasini baholash imkonini beradi.

Raqobatchilar tahlili

ImmunityBio Inc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Immunocore Corp IMCR|JANX - Narxning prognoz qilingan daromadga nisbati|RCUS (arcusbio.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Zymeworks Biopharmaceuticals (ZYME) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Tango Pharma (TNGX)|Forvard narx/daromad multiplikatori IOVA|IMTX - Prognoz narxning daromadga nisbati|Forvard narx/daromad multiplikatori XNCR (Xencor Corp)|Narxning kutilayotgan daromadga nisbati CMPX|Forvard P/S multiplikatori REPL (Replimune)|Sotuvga nisbatan forvard narx LYEL|innate-pharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Pyxis Oncology|Compugen Limited (CGEN) - Narxning prognoz qilingan daromadga nisbati|IO Biotech, Inc. - Sotuvga nisbatan forvard narx|STRO (sutrobio.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori MiNK Therapeutics Inc.|Narxning prognoz qilingan daromadga nisbati werewolftx.com (HOWL)|IMMX: Kelajakdagi narxning daromadga nisbati|alxoncology.com - Forvard narx/daromad multiplikatori|CUE - Forvard narx/daromad multiplikatori|PDSB - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Sonnet BioTherapeutics Holdings SONN|MAIA: Forvard P/S multiplikatori|LIMN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori LVTX|Kapitalizatsiyaning prognoz qilingan daromadga nisbati NXTC (NextCure)|Narxning prognoz qilingan daromadga nisbati leaptx.com (LPTX)|INTS - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori SNSE (Sensei Biotherapeutics, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gritstonebio.com (GRTS)|kinetabio.com - Forvard P/S multiplikatori|NexImmune (NEXI) - Forvard narx/daromad multiplikatori|turnstonebio.com (TSBX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vaccinex, Inc (VCNX)|Forvard narx/daromad multiplikatori HARP